Tailored cancer treatment: Research predicts which patients benefit from immunotherapy
byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1
Updated on: January 22,2025
Tailored cancer treatment: Research predicts which patients benefit from immunotherapy
byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1
Updated on:January 22,2025
